Loading
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (15 ops.)
Latest filing published 26 May 2017 for Magellan Health INC.
Insider track record
Disclosed buys
3
Disclosed sells
15
Signal history
No signal scores available.
Closed purchases
Market purchases
3
Positive at T+90
33%
Median T+90
-8.2%
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +6.0%Entry US$63.00 · Close at T+365 US$66.80
- -9.4%Entry US$70.73 · Close at T+365 US$64.09
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kay Coles James: trading record in brief
This profile gathers the share dealings of Kay Coles James across 3 companies, led by Amerigroup Corp, PNC Financial Services Group, Inc. and Magellan Health Inc. The record holds 41 filings, for trades running from 10 May 2006 to 24 May 2017.
On the open market, the record shows 3 purchases worth €14k and 15 sales worth €2.9M. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 16 share grants and 6 option exercises.
The median purchase comes to €4,493. After 3 purchases with a full 90-day history, the hit rate stands at 33% and the median 90-day move at -8.2%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 26 May 2017, reports a share grant in Magellan Health Inc. The most recent open-market purchase was published on 13 March 2012, 5,337 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kay Coles James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
2,137 shares0Ordinary Common Stock, $0.01 par valueSEC:0001209191-17-035741:0
2,295 shares0Ordinary Common Stock, $0.01 par valueSEC:0001209191-16-121973:0
2,235 shares0Ordinary Common Stock, $0.01 par valueSEC:0001209191-15-046073:0
2,235 shares0Ordinary Common Stock, $0.01 par valueSEC:0001209191-15-046074:0
1,642 shares0Ordinary Common Stock, $0.01 par valueSEC:0001181431-14-027307:0
12,850 shares@ US$92.00Common StockSEC:0001225208-12-026065:0
2,777 shares0Common StockSEC:0001225208-12-014140:0
100 shares@ US$59.64$5 Par Common StockSEC:0001209191-12-017865:0
Canonical exit: 7 Jun 2012 (T+90)
200 shares@ US$59.64$5 Par Common StockSEC:0001209191-12-017865:1
Canonical exit: 7 Jun 2012 (T+90)
6,441 shares@ US$27.55Common StockSEC:0001225208-12-004719:0
3,115 shares@ US$31.44Common StockSEC:0001225208-12-004719:1
9,556 shares@ US$75.00Common StockSEC:0001225208-12-004719:2
7,897 shares@ US$25.75Common StockSEC:0001225208-12-001519:0
6,415 shares@ US$25.63Common StockSEC:0001225208-12-001519:1
14,312 shares@ US$70.00Common StockSEC:0001225208-12-001519:2
2,509 shares0Common StockSEC:0001225208-11-014401:0
5,930 shares@ US$38.69Common StockSEC:0001225208-11-013329:0
616 shares@ US$67.95Common StockSEC:0001225208-11-013329:1
5,314 shares@ US$67.10Common StockSEC:0001225208-11-013329:2
20,070 shares@ US$38.69Common StockSEC:0001225208-11-013329:3
15,070 shares@ US$66.21Common StockSEC:0001225208-11-013329:4
200 shares@ US$69.61Common StockSEC:0001225208-11-012966:0
1,900 shares@ US$68.79Common StockSEC:0001225208-11-012966:1
2,500 shares@ US$43.98Common StockSEC:0001225208-10-026091:0
249 shares@ US$60.22$5 Par Common StockSEC:0001209191-10-041271:0
25 of 40 declarations
